SK287223B6 - Použitie komplexu kyseliny hyalurónovej a zinku pri liečení artritického ochorenia - Google Patents

Použitie komplexu kyseliny hyalurónovej a zinku pri liečení artritického ochorenia Download PDF

Info

Publication number
SK287223B6
SK287223B6 SK1250-2001A SK12502001A SK287223B6 SK 287223 B6 SK287223 B6 SK 287223B6 SK 12502001 A SK12502001 A SK 12502001A SK 287223 B6 SK287223 B6 SK 287223B6
Authority
SK
Slovakia
Prior art keywords
hyaluronic acid
zinc
complex
synovial
mmp
Prior art date
Application number
SK1250-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK12502001A3 (sk
Inventor
Isao Serizawa
Keisei Maekawa
Janos Illes
Erzsebet Neszmeli
Original Assignee
Takata Seiyaku Co., Ltd.
Richter Gedeon Vegy�Szeti Gy�R Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takata Seiyaku Co., Ltd., Richter Gedeon Vegy�Szeti Gy�R Rt. filed Critical Takata Seiyaku Co., Ltd.
Publication of SK12502001A3 publication Critical patent/SK12502001A3/sk
Publication of SK287223B6 publication Critical patent/SK287223B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1250-2001A 1999-03-10 2000-03-10 Použitie komplexu kyseliny hyalurónovej a zinku pri liečení artritického ochorenia SK287223B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP06371899A JP2003089647A (ja) 1999-03-10 1999-03-10 関節性疾患治療剤
PCT/JP2000/001487 WO2000053194A1 (fr) 1999-03-10 2000-03-10 Medicaments contre les affections articulaires

Publications (2)

Publication Number Publication Date
SK12502001A3 SK12502001A3 (sk) 2002-02-05
SK287223B6 true SK287223B6 (sk) 2010-03-08

Family

ID=13237463

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1250-2001A SK287223B6 (sk) 1999-03-10 2000-03-10 Použitie komplexu kyseliny hyalurónovej a zinku pri liečení artritického ochorenia

Country Status (21)

Country Link
US (1) US6608043B1 (ja)
EP (1) EP1166788B8 (ja)
JP (1) JP2003089647A (ja)
KR (1) KR100728096B1 (ja)
CN (1) CN1165315C (ja)
AT (1) ATE466584T1 (ja)
AU (1) AU2942500A (ja)
BG (1) BG65681B1 (ja)
CA (1) CA2364451C (ja)
CY (1) CY1109773T1 (ja)
CZ (1) CZ301736B6 (ja)
DE (1) DE60044341D1 (ja)
DK (1) DK1166788T3 (ja)
EA (1) EA005010B1 (ja)
EE (1) EE04660B1 (ja)
ES (1) ES2344677T3 (ja)
PL (1) PL200848B1 (ja)
PT (1) PT1166788E (ja)
SK (1) SK287223B6 (ja)
UA (1) UA72913C2 (ja)
WO (1) WO2000053194A1 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
ITRM20030590A1 (it) * 2003-12-22 2005-06-23 Univ Siena Formulazione a base di polimetafosfati per la cura di artropatie microcristalline.
JPWO2005089800A1 (ja) * 2004-03-17 2008-01-31 株式会社ロコモジェン ｈｓＨＲＤ３を含む医薬組成物
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
NO20064337L (no) * 2005-09-26 2007-03-27 Glycoscience Lab Inc Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
WO2008068854A1 (ja) 2006-12-05 2008-06-12 Glycoscience Laboratories, Inc. 変形性関節症の治療剤
FR2927255B1 (fr) * 2008-02-07 2011-08-12 Keysan Consulting Produits injectables biocompatibles a liberation de zinc et/ou de sel de saccharide sous forme de zinc et leurs utilisations.
US8462765B2 (en) * 2008-08-20 2013-06-11 Qualcomm Incorporated Method and apparatus to perform ranging operations for wireless stations
JP5587637B2 (ja) * 2009-04-10 2014-09-10 生化学工業株式会社 マトリックスメタロプロテアーゼ阻害剤及びその用途
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
EP2545925B1 (en) * 2011-07-12 2018-02-14 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
EP0259485A4 (en) * 1986-03-14 1988-07-29 Bio Technology General Corp HEAVY METAL SALTS OF HYALURONIC ACID FOR USE AS AN ANTIMICROBIAL AGENT.
AU604542B2 (en) 1987-03-19 1990-12-20 Arthropharm Pty Ltd Polysulphated polysaccharide complexes
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
CZ202591A3 (cs) * 1991-07-02 1993-01-13 Hypro Vyzkum Prostředek pro prevenci dekubitft a topickou terapii kožních lézt
US5744442A (en) * 1992-08-26 1998-04-28 Bristol Meyers Squibb Company Regulation of cellular invasiveness
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
IT1288290B1 (it) 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
EP0834319A1 (en) * 1996-10-07 1998-04-08 Kartar Dr. Lalvani Mineral and vitamin combinations in arthritic pain

Also Published As

Publication number Publication date
CN1165315C (zh) 2004-09-08
CA2364451C (en) 2011-08-02
PL350289A1 (en) 2002-12-02
CZ20013110A3 (cs) 2002-01-16
ATE466584T1 (de) 2010-05-15
EP1166788B1 (en) 2010-05-05
EP1166788A1 (en) 2002-01-02
BG65681B1 (bg) 2009-06-30
US6608043B1 (en) 2003-08-19
CA2364451A1 (en) 2000-09-14
EE04660B1 (et) 2006-08-15
CN1343122A (zh) 2002-04-03
EP1166788B8 (en) 2010-06-16
EP1166788A4 (en) 2007-10-10
AU2942500A (en) 2000-09-28
KR20010108343A (ko) 2001-12-07
PL200848B1 (pl) 2009-02-27
ES2344677T3 (es) 2010-09-03
EA005010B1 (ru) 2004-10-28
CZ301736B6 (cs) 2010-06-09
KR100728096B1 (ko) 2007-06-14
JP2003089647A (ja) 2003-03-28
PT1166788E (pt) 2010-06-25
EA200100963A1 (ru) 2002-02-28
DE60044341D1 (de) 2010-06-17
UA72913C2 (en) 2005-05-16
SK12502001A3 (sk) 2002-02-05
WO2000053194A1 (fr) 2000-09-14
BG105885A (en) 2002-06-28
DK1166788T3 (da) 2010-08-23
EE200100478A (et) 2003-02-17
CY1109773T1 (el) 2014-09-10

Similar Documents

Publication Publication Date Title
SK287223B6 (sk) Použitie komplexu kyseliny hyalurónovej a zinku pri liečení artritického ochorenia
AU2006220034B2 (en) Amide derivatives of hyaluronic acid in osteoarthrosis
US20060009397A1 (en) New use
JPH01279828A (ja) 脈管形成阻止剤
JPH06507635A (ja) 病理学的過程の予防および／または治療用組成物
US8604003B2 (en) Promoter for hard tissue formation
US20010036934A1 (en) Use of chitinous materials for inhibiting cellular nitric oxide production
JP3751202B2 (ja) 関節性疾患治療剤
Chang Immunoregulatory effects of a synthetic monosaccharide
EP2318014B1 (en) New composition for treating autoimmune disorders
ZA200108544B (en) A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug.
KR20010011926A (ko) 골다공증 예방 및 치료제 조성물

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20200310